Randomized Phase 2 (Ph2) clinical trial of Lerapolturev (previously known as PVSRIPO) in recurrent glioblastoma (rGBM)
Clinical Trial Grant
Administered By
Neurosurgery, Neuro-Oncology
Awarded By
Brain Tumor Research Charity
Start Date
May 1, 2024
End Date
April 30, 2027
Administered By
Neurosurgery, Neuro-Oncology
Awarded By
Brain Tumor Research Charity
Start Date
May 1, 2024
End Date
April 30, 2027